WebNov 18, 2024 · Hallura Ltd., an Israeli based aesthetic medical company developing a new generation of Hyaluronic Acid (HA) Dermal Fillers, closes its A round of $7M. The financing round was led by a group of US, Europe and Israel-based private investors; most of the investment comes from leading plastic surgeons and dermatologists. WebMar 2, 2024 · Hallura Ltd’s hyaluronic acid (HA) dermal fillers with its proprietary BiOLinkMatrix platform performed well for lip enhancement, nasolabial folds correction. and cheek enhancement, according to topline results.. The proprietary BiOLinkMatrix technology is a smooth crosslinking method enabling a lower HA concentration and a reduction in …
Aesthetic Injectables Devices Pipeline Product Landscape Report …
WebMar 2, 2024 · Hallura Ltd. a portfolio company of Alon Medtech Ventures owned by Dr. Shimon Eckhouse, brings a disruptive HA technology to the fast-growing aesthetic … WebJul 22, 2024 · Evaluation of the safety and performance of the investigational device in its three concentrations for cheek and lips augmentation and correction of the nasolabial … podcasts for math teachers
Shimon Eckhouse - Biography - MarketScreener.com
WebNov 10, 2024 · Hallura Ltd. a portfolio company of Alon Medtech Ventures owned by Dr. Shimon Eckhouse, brings a disruptive HA technology to the fast-growing aesthetic injectables market using proprietary HA ... WebJul 1, 2024 · Hallura is an aesthetic medical company developing a new generation of hyaluronic acid (HA) dermal fillers. Its products are based on a crosslinking mechanism … WebDN COMPANY - DAEWOONG PHARMACEUTICAL RELATED. 2015년 5월 - 2024년 9월2년 5개월. Seoul, Korea. No. 1 Aesthetics Company in Korea to expand its business domain Globally. - Botulinum Toxin Type A, HA/Calcium Hydroxylapatite filler, Cosmeceutical etc. - License in/out. podcasts for life improvement